Inicio Área de profesionales Artículos publicados Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study.

Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study.

Correo electrónico Imprimir

Emilio Alba, Miguel Martin, Manuel Ramos, Encarna Adrover, Ana Balil, Carlos Jara, Agusti Barnadas, Antonio Fernández-Aramburo, Pedro Sánchez-Rovira, Margarita Amenedo, Antonio Casado. Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study. Journal of Clinical Oncology 2004; 22(13):2587-2593.

Para más información vaya al siguiente enlace:

http://jco.ascopubs.org/cgi/content/full/22/13/2587